Ardsley Advisory Partners LP Standard Biotools Inc. Transaction History

Ardsley Advisory Partners LP

  • $568 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$5.45 - $8.65 $163,500 - $259,500
-30,000 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$4.34 - $11.43 $43,400 - $114,300
-10,000 Reduced 25.0%
30,000 $223,000
Q2 2020

Aug 14, 2020
BUY
$1.85 - $5.29 $74,000 - $211,600
40,000 New
40,000 $160,000

Others Institutions Holding LAB

# of Institutions
143
Shares Held
274M
Call Options Held
6.7K
Put Options Held
48.7K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $95.2M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email